Latest Financials News

Page 3 of 1946
Dotz Nano has repriced its A$2 million placement after CEO and director Nati Harpaz resigned for health reasons, increasing the proposed share issue while adding more generous attaching options. The company has also clarified that its September quarterly report described commitments as a completed raise even though no shares or funds had then changed hands.
Victor Sage
Victor Sage
18 Nov 2026
Shriro Holdings delivered a sharp FY26 profit increase, but is guiding to lower EBITDA in FY27 as it funds the launch of its Everdure Lagoon BBQ range and absorbs normalised calculator sales. The debt-free group says its balance sheet still gives it room to invest, return capital and pursue acquisitions.
Victor Sage
Victor Sage
18 Nov 2026
ParagonCare says it achieved its FY26 guidance and lifted underlying EBITDA 16.5% to $97.2 million, despite a statutory earnings hit from the Infinity Pharmacy Group bad debt. The healthcare distributor is now turning to Asian expansion, operational efficiency and an active share buyback in FY27.
Ada Torres
Ada Torres
18 Nov 2026
Yowie Group has appointed GBA Capital and Boston Global to lead a proposed A$2.5 million placement, with the company’s shares still suspended from ASX trading. The raising is intended to support a shift towards a multi-brand confectionery business and help satisfy the conditions for a possible reinstatement.
Victor Sage
Victor Sage
18 Nov 2026
Australian Vintage says its FY26 turnaround has restored positive free cash flow excluding growth investments, while Poco Vino sales and international expansion gather pace. The wine group is targeting a return to net cash in FY27, but has also withdrawn its 2040 net-zero emissions target.
Victor Sage
Victor Sage
18 Nov 2026
Western Mines Group is positioning Mulga Tank for its next valuation test: a scoping study on a shallow, low-grade resource containing 7.2 million tonnes of nickel. The company is also pursuing deeper, potentially higher-grade sulphide zones, while its capital structure leaves little room for costly detours.
Maxwell Dee
Maxwell Dee
18 Nov 2026
Genetic Signatures has abandoned its proposed merger with Microba Life Sciences after Microba said it lacked the financial capacity to complete the transaction without fresh capital. GSS also declined to provide unsecured working capital funding, leaving the shareholder vote and Takeovers Panel process to be unwound separately.
Ada Torres
Ada Torres
18 Nov 2026
Genetic Signatures has ended its proposed merger with Microba Life Sciences after Microba said it could not complete the transaction without raising more capital. The decision also removes the deal’s shareholder vote and leaves a Takeovers Panel application awaiting clarification.
Ada Torres
Ada Torres
18 Nov 2026
IDT Australia expects FY27 revenue of $19 million to $20 million and EBITDA of $1 million to $1.5 million, marking a projected swing from a $0.92 million FY26 loss. The forecast rests on larger customer contracts, a five-year radiopharmaceutical deal and roughly $7 million of manufacturing upgrades.
Victor Sage
Victor Sage
18 Nov 2026
Cettire has started FY27 with stronger revenue, improved margins and a 50% lift in adjusted EBITDA, although US sales fell 3% and cash declined from a year earlier. The luxury e-commerce group is now targeting ongoing profitability in the second quarter.
Victor Sage
Victor Sage
18 Nov 2026
Ecolab is expanding its One Ecolab programme and expects US$600 million in combined restructuring costs and special charges through 2030. Most restructuring spending is expected to be cash severance costs as teams are shifted into global centres of excellence.
Maxwell Dee
Maxwell Dee
18 Nov 2026
SEEK has left its FY27 financial guidance unchanged despite ANZ hiring volumes tracking down by a mid-single-digit percentage. Yield growth of about 10% remains on track, leaving pricing and monetisation to offset softer recruitment activity.
Sophie Babbage
Sophie Babbage
18 Nov 2026

Browse the archive

Full archive